Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Oncologic Outcomes of Adjuvant versus Salvage Radiotherapy after Prostatectomy.

Seddik S, Silva M, Dugué AE, Ait Said K, Joly F, Tillou X.

Urol Int. 2019 Jun 21:1-7. doi: 10.1159/000501086. [Epub ahead of print]

PMID:
31230046
2.

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.

Fossati N, Karnes RJ, Boorjian SA, Moschini M, Morlacco A, Bossi A, Seisen T, Cozzarini C, Fiorino C, Noris Chiorda B, Gandaglia G, Dell'Oglio P, Joniau S, Tosco L, Shariat S, Goldner G, Hinkelbein W, Bartkowiak D, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A.

Eur Urol. 2017 Jun;71(6):886-893. doi: 10.1016/j.eururo.2016.07.028. Epub 2016 Jul 30.

PMID:
27484843
3.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
4.
5.

Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?

Hsu CC, Paciorek AT, Cooperberg MR, Roach M 3rd, Hsu IC, Carroll PR.

BJU Int. 2015 Nov;116(5):713-20. doi: 10.1111/bju.13043. Epub 2015 May 26.

6.

Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.

Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.

Cancer J Sci Am. 1998 Sep-Oct;4(5):324-30.

PMID:
9815297
7.
8.

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.

Schmidt-Hegemann NS, Fendler WP, Ilhan H, Herlemann A, Buchner A, Stief C, Eze C, Rogowski P, Li M, Bartenstein P, Ganswindt U, Belka C.

Radiat Oncol. 2018 Mar 2;13(1):37. doi: 10.1186/s13014-018-0983-4.

9.

Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.

Wadasaki K, Kaneyasu Y, Kenjo M, Matsuura K, Murakami Y, Hashimoto Y, Ito K, Kiriu H, Ito A.

Int J Clin Oncol. 2007 Feb;12(1):37-41. Epub 2007 Feb 25.

PMID:
17380439
10.
11.

Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy.

Monti CR, Nakamura RA, Ferrigno R, Rossi A Jr, Kawakami NS, Trevisan FA.

Int Braz J Urol. 2006 Jul-Aug;32(4):416-26; discussion 427.

12.

Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.

Casas F, Valduvieco I, Oses G, Izquierdo L, Archila I, Costa M, Cortes KS, Barreto T, Ferrer F.

Clin Transl Oncol. 2019 Mar;21(3):355-362. doi: 10.1007/s12094-018-1931-3. Epub 2018 Aug 20.

PMID:
30128953
13.

Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy.

Lee LW, McBain CA, Swindell R, Wylie JP, Cowan RA, Logue JP.

Clin Oncol (R Coll Radiol). 2004 Dec;16(8):517-22.

PMID:
15630843
14.

Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?

King CR, Presti JC Jr, Gill H, Brooks J, Hancock SL.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):341-7.

PMID:
15145146
15.

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.

Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019. Review.

PMID:
17054269
16.

Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy.

Breeuwsma AJ, Rybalov M, Leliveld AM, Pruim J, de Jong IJ.

Q J Nucl Med Mol Imaging. 2012 Oct;56(5):440-6.

PMID:
23069923
17.

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED.

JAMA. 2006 Nov 15;296(19):2329-35.

PMID:
17105795
18.

Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.

Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.

Urology. 2004 Jul;64(1):84-9.

PMID:
15245941
19.

Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.

Tilki D, Preisser F, Tennstedt P, Tober P, Mandel P, Schlomm T, Steuber T, Huland H, Schwarz R, Petersen C, Graefen M, Ahyai S.

BJU Int. 2017 May;119(5):717-723. doi: 10.1111/bju.13679. Epub 2016 Nov 21.

20.

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA.

J Clin Oncol. 2003 Feb 1;21(3):483-9.

PMID:
12560439

Supplemental Content

Support Center